Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins
Prepn. for the enteral mourishment of onbological patients, comprising fats and opt. carbohydrates and/or proteins as well as the usual additives, is improved in that the fat comprises the following formulation and is either in the free state or compatible salt and/or ester (1) 30-35 (37-55) wt.% ol...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KESSLER, BARBARA., 6242 KRONBERG, DE RIEDEL, ANGELIKA, 6394 GRAEVENWIESBACH, DE SCHULZ, SABINE., 6300 GIESSEN, DE ROOSEN, URSULA, 6900 HEIDELBERG, DE |
| description | Prepn. for the enteral mourishment of onbological patients, comprising fats and opt. carbohydrates and/or proteins as well as the usual additives, is improved in that the fat comprises the following formulation and is either in the free state or compatible salt and/or ester (1) 30-35 (37-55) wt.% oleic acid; (2) 3-20 (5-15) wt.% linoleic acid, (3) 0.5-8 (0.8-5) wt.% alpha linolenic acid, (4) 1-10 (1.5-5) wt.% eicosapentanoic and docosahexanoic and (5) 0-0.6 (0-0.5) omega-3-aliphatic acid. Pref. ratio of omega-3-fatty acids to omega-6-fatty acids is 1:2.1-1:3 (1:2.3-1:2.7). The aliphatic acid is used (partly) as an oil. The oleic acid is used in the form of a vegetable oil contg. at least 75%, oleic acid. The linoleic acid is used an oil rich in linoleic acid (contact at least 70%). The content of alpha-linolenic acid is supplied by an oil contg. at least 45% alpha-linolenic acid. The eicoso-pentanoic and docosahexanoic used as fish oil contg. at least 30% omega-3-aliphatic acids. The formulation also contains medium chain length triglycenides in amt. of 10-20 wt.%. The formulation provides 40-65 (50)% energy, through the fats, 12-25 (18)% energy through the proteins and 20-45(32)% energy through the carbohydrates. The formulation also cotnains nuclestides, vitamins, minerals and/or trace elements as well as ballasts. It is used as a drink and/or food. ADVANTAGE - The prepn. is compatible and suits the metabolism of onbologic patients better than known prods |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE4304394A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE4304394A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE4304394A13</originalsourceid><addsrcrecordid>eNqNyzEOwjAMheEuDAi4gw9AI1C7MCIoYmRgr0zqtpFSO0rSgcNwVyyEmJksff_zsnjdIgU20EsEljm6NE7EGaQHYSteBmfRQ8DslBOUYGUKOqMEPSro4zR7zcKaOA8GxJOzgNZ1W0AfRiy9Y0X-KWVrtHEHErIBi_Eh47OLmOmjIUomx2ldLHr0iTbfuyrg0txP15KCtJQCWmLK7bmpq11dHerjvvpj8gbq21KP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins</title><source>esp@cenet</source><creator>KESSLER, BARBARA., 6242 KRONBERG, DE ; RIEDEL, ANGELIKA, 6394 GRAEVENWIESBACH, DE ; SCHULZ, SABINE., 6300 GIESSEN, DE ; ROOSEN, URSULA, 6900 HEIDELBERG, DE</creator><creatorcontrib>KESSLER, BARBARA., 6242 KRONBERG, DE ; RIEDEL, ANGELIKA, 6394 GRAEVENWIESBACH, DE ; SCHULZ, SABINE., 6300 GIESSEN, DE ; ROOSEN, URSULA, 6900 HEIDELBERG, DE</creatorcontrib><description>Prepn. for the enteral mourishment of onbological patients, comprising fats and opt. carbohydrates and/or proteins as well as the usual additives, is improved in that the fat comprises the following formulation and is either in the free state or compatible salt and/or ester (1) 30-35 (37-55) wt.% oleic acid; (2) 3-20 (5-15) wt.% linoleic acid, (3) 0.5-8 (0.8-5) wt.% alpha linolenic acid, (4) 1-10 (1.5-5) wt.% eicosapentanoic and docosahexanoic and (5) 0-0.6 (0-0.5) omega-3-aliphatic acid. Pref. ratio of omega-3-fatty acids to omega-6-fatty acids is 1:2.1-1:3 (1:2.3-1:2.7). The aliphatic acid is used (partly) as an oil. The oleic acid is used in the form of a vegetable oil contg. at least 75%, oleic acid. The linoleic acid is used an oil rich in linoleic acid (contact at least 70%). The content of alpha-linolenic acid is supplied by an oil contg. at least 45% alpha-linolenic acid. The eicoso-pentanoic and docosahexanoic used as fish oil contg. at least 30% omega-3-aliphatic acids. The formulation also contains medium chain length triglycenides in amt. of 10-20 wt.%. The formulation provides 40-65 (50)% energy, through the fats, 12-25 (18)% energy through the proteins and 20-45(32)% energy through the carbohydrates. The formulation also cotnains nuclestides, vitamins, minerals and/or trace elements as well as ballasts. It is used as a drink and/or food. ADVANTAGE - The prepn. is compatible and suits the metabolism of onbologic patients better than known prods</description><language>eng</language><subject>FOODS OR FOODSTUFFS ; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J ; HUMAN NECESSITIES ; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL ; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT ; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</subject><creationdate>1993</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19930902&DB=EPODOC&CC=DE&NR=4304394A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19930902&DB=EPODOC&CC=DE&NR=4304394A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KESSLER, BARBARA., 6242 KRONBERG, DE</creatorcontrib><creatorcontrib>RIEDEL, ANGELIKA, 6394 GRAEVENWIESBACH, DE</creatorcontrib><creatorcontrib>SCHULZ, SABINE., 6300 GIESSEN, DE</creatorcontrib><creatorcontrib>ROOSEN, URSULA, 6900 HEIDELBERG, DE</creatorcontrib><title>Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins</title><description>Prepn. for the enteral mourishment of onbological patients, comprising fats and opt. carbohydrates and/or proteins as well as the usual additives, is improved in that the fat comprises the following formulation and is either in the free state or compatible salt and/or ester (1) 30-35 (37-55) wt.% oleic acid; (2) 3-20 (5-15) wt.% linoleic acid, (3) 0.5-8 (0.8-5) wt.% alpha linolenic acid, (4) 1-10 (1.5-5) wt.% eicosapentanoic and docosahexanoic and (5) 0-0.6 (0-0.5) omega-3-aliphatic acid. Pref. ratio of omega-3-fatty acids to omega-6-fatty acids is 1:2.1-1:3 (1:2.3-1:2.7). The aliphatic acid is used (partly) as an oil. The oleic acid is used in the form of a vegetable oil contg. at least 75%, oleic acid. The linoleic acid is used an oil rich in linoleic acid (contact at least 70%). The content of alpha-linolenic acid is supplied by an oil contg. at least 45% alpha-linolenic acid. The eicoso-pentanoic and docosahexanoic used as fish oil contg. at least 30% omega-3-aliphatic acids. The formulation also contains medium chain length triglycenides in amt. of 10-20 wt.%. The formulation provides 40-65 (50)% energy, through the fats, 12-25 (18)% energy through the proteins and 20-45(32)% energy through the carbohydrates. The formulation also cotnains nuclestides, vitamins, minerals and/or trace elements as well as ballasts. It is used as a drink and/or food. ADVANTAGE - The prepn. is compatible and suits the metabolism of onbologic patients better than known prods</description><subject>FOODS OR FOODSTUFFS</subject><subject>FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J</subject><subject>HUMAN NECESSITIES</subject><subject>PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL</subject><subject>THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT</subject><subject>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1993</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyzEOwjAMheEuDAi4gw9AI1C7MCIoYmRgr0zqtpFSO0rSgcNwVyyEmJksff_zsnjdIgU20EsEljm6NE7EGaQHYSteBmfRQ8DslBOUYGUKOqMEPSro4zR7zcKaOA8GxJOzgNZ1W0AfRiy9Y0X-KWVrtHEHErIBi_Eh47OLmOmjIUomx2ldLHr0iTbfuyrg0txP15KCtJQCWmLK7bmpq11dHerjvvpj8gbq21KP</recordid><startdate>19930902</startdate><enddate>19930902</enddate><creator>KESSLER, BARBARA., 6242 KRONBERG, DE</creator><creator>RIEDEL, ANGELIKA, 6394 GRAEVENWIESBACH, DE</creator><creator>SCHULZ, SABINE., 6300 GIESSEN, DE</creator><creator>ROOSEN, URSULA, 6900 HEIDELBERG, DE</creator><scope>EVB</scope></search><sort><creationdate>19930902</creationdate><title>Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins</title><author>KESSLER, BARBARA., 6242 KRONBERG, DE ; RIEDEL, ANGELIKA, 6394 GRAEVENWIESBACH, DE ; SCHULZ, SABINE., 6300 GIESSEN, DE ; ROOSEN, URSULA, 6900 HEIDELBERG, DE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE4304394A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1993</creationdate><topic>FOODS OR FOODSTUFFS</topic><topic>FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J</topic><topic>HUMAN NECESSITIES</topic><topic>PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL</topic><topic>THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT</topic><topic>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</topic><toplevel>online_resources</toplevel><creatorcontrib>KESSLER, BARBARA., 6242 KRONBERG, DE</creatorcontrib><creatorcontrib>RIEDEL, ANGELIKA, 6394 GRAEVENWIESBACH, DE</creatorcontrib><creatorcontrib>SCHULZ, SABINE., 6300 GIESSEN, DE</creatorcontrib><creatorcontrib>ROOSEN, URSULA, 6900 HEIDELBERG, DE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KESSLER, BARBARA., 6242 KRONBERG, DE</au><au>RIEDEL, ANGELIKA, 6394 GRAEVENWIESBACH, DE</au><au>SCHULZ, SABINE., 6300 GIESSEN, DE</au><au>ROOSEN, URSULA, 6900 HEIDELBERG, DE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins</title><date>1993-09-02</date><risdate>1993</risdate><abstract>Prepn. for the enteral mourishment of onbological patients, comprising fats and opt. carbohydrates and/or proteins as well as the usual additives, is improved in that the fat comprises the following formulation and is either in the free state or compatible salt and/or ester (1) 30-35 (37-55) wt.% oleic acid; (2) 3-20 (5-15) wt.% linoleic acid, (3) 0.5-8 (0.8-5) wt.% alpha linolenic acid, (4) 1-10 (1.5-5) wt.% eicosapentanoic and docosahexanoic and (5) 0-0.6 (0-0.5) omega-3-aliphatic acid. Pref. ratio of omega-3-fatty acids to omega-6-fatty acids is 1:2.1-1:3 (1:2.3-1:2.7). The aliphatic acid is used (partly) as an oil. The oleic acid is used in the form of a vegetable oil contg. at least 75%, oleic acid. The linoleic acid is used an oil rich in linoleic acid (contact at least 70%). The content of alpha-linolenic acid is supplied by an oil contg. at least 45% alpha-linolenic acid. The eicoso-pentanoic and docosahexanoic used as fish oil contg. at least 30% omega-3-aliphatic acids. The formulation also contains medium chain length triglycenides in amt. of 10-20 wt.%. The formulation provides 40-65 (50)% energy, through the fats, 12-25 (18)% energy through the proteins and 20-45(32)% energy through the carbohydrates. The formulation also cotnains nuclestides, vitamins, minerals and/or trace elements as well as ballasts. It is used as a drink and/or food. ADVANTAGE - The prepn. is compatible and suits the metabolism of onbologic patients better than known prods</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_DE4304394A1 |
| source | esp@cenet |
| subjects | FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES |
| title | Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T18%3A15%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KESSLER,%20BARBARA.,%206242%20KRONBERG,%20DE&rft.date=1993-09-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE4304394A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |